Yap1 AS A THERAPEUTIC TARGET IN FIBROLAMELLAR CARCINOMA

被引:0
|
作者
Oh, Seh-Hoon [1 ]
Jewell, Mark [2 ]
Premont, Richard T. [3 ]
Gibson, Jason [4 ]
Glover, Wayne [5 ]
Gregory, Simon G. [4 ]
Hsu, David [5 ]
Guy, Cynthia D. [6 ]
Diehl, Anna Mae [7 ]
机构
[1] Duke Univ, Med, Durham, NC 27706 USA
[2] Duke Univ, Dept Med, Durham, NC 27706 USA
[3] Duke Univ, Durham, NC 27706 USA
[4] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27706 USA
[5] Duke Univ, Duke Canc Inst, Durham, NC 27706 USA
[6] Duke Univ, Pathol, Durham, NC 27706 USA
[7] Duke Univ, Div Gastroenterol, Dept Med, Durham, NC USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1474
引用
收藏
页码:888A / 889A
页数:2
相关论文
共 50 条
  • [21] YAP1 meets tumor suppression
    Strano, Sabrina
    Blandino, Giovanni
    MOLECULAR CELL, 2007, 27 (06) : 863 - 864
  • [22] Clinical significance of YAP1 activation in head and neck squamous cell carcinoma
    Eun, Young-Gyu
    Lee, Dongjin
    Lee, Young Chan
    Sohn, Bo Hwa
    Kim, Eui Hyun
    Yim, Sun Young
    Kwon, Kee Hwan
    Lee, Ju-Seog
    ONCOTARGET, 2017, 8 (67) : 111130 - 111143
  • [23] Activation of YAP1 by STK25 contributes to the progression of hepatocellular carcinoma
    Jiang, Jiong
    Zheng, Ying
    Chen, Fenrong
    Dong, Lei
    Guo, Xiaoyan
    TISSUE & CELL, 2022, 76
  • [24] Inhibition of thyroid carcinoma cells with YAP1 protein interference and its mechanism
    Huang, C-Y
    Han, Z.
    Li, X.
    Xie, H-H
    Zhu, S-S
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (08) : 2351 - 2355
  • [25] YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma
    Omori, Hirofumi
    Nishio, Miki
    Masuda, Muneyuki
    Miyachi, Yosuke
    Ueda, Fumihito
    Nakano, Takafumi
    Sato, Kuniaki
    Mimori, Koshi
    Taguchi, Kenichi
    Hikasa, Hiroki
    Nishina, Hiroshi
    Tashiro, Hironori
    Kiyono, Tohru
    Mak, Tak Wah
    Nakao, Kazuwa
    Nakagawa, Takashi
    Maehama, Tomohiko
    Suzuki, Akira
    SCIENCE ADVANCES, 2020, 6 (12)
  • [26] The Current Progress of Oncoprotein YAP1
    Guo Hai-Qiang
    Liu Tong-Yang
    Jia Shu-Ting
    Luo Ying
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2015, 42 (03) : 254 - 259
  • [27] MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1
    Zhang, Hui
    Liu, Hui
    Bi, Huaqiang
    ONCOLOGY REPORTS, 2017, 38 (02) : 843 - 849
  • [28] ONCOGENES All eyes on YAP1
    Seton-Rogers, Sarah
    NATURE REVIEWS CANCER, 2014, 14 (08) : 515 - 515
  • [29] A rare sarcoma with YAP1::KMT2A::YAP1 fusion arising from the abdominal wall
    Nam, M. H.
    Kao, Y.
    VIRCHOWS ARCHIV, 2024, 485 : S373 - S374
  • [30] Advances in research on the carcinogenic mechanisms and therapeutic potential of YAP1 in bladder cancer (Review)
    Huang, Tianyu
    Fan, Longmei
    Tang, Jiajia
    Chen, Shicheng
    Du, Guotu
    Zhang, Neng
    ONCOLOGY REPORTS, 2025, 53 (01)